A multicenter phase II trial of nab-paclitaxel and capecitabine in HER-2 negative and triple- negative advanced breast cancer: Could be an old regimen a valid approach to a changing disease?

Authors :: Ciccarese M
Orlando L
Fedele P
Schiavone P
Maiello E
Cilenti G
Aieta M
Bozza G
Forcignanò R
Febbraro A
Bordonaro R
Romito S
Rinaldi A
Borsellino N
Riccardi F
Pisconti S
Lorusso V
Colucci G
Surico G
Saracino V
Cinieri S
Source :: The breast journal [Breast J] 2020 Sep; Vol. 26 (9), pp. 1857-1859. Date of Electronic Publication: 2020 May 20.
Publication Year :: 2020

Subjects :: Albumins
Antineoplastic Combined Chemotherapy Protocols adverse effects
Capecitabine adverse effects
Female
Humans
Paclitaxel adverse effects
Breast Neoplasms drug therapy
Triple Negative Breast Neoplasms drug therapy

Full Text Access

Tools